40
Views
16
CrossRef citations to date
0
Altmetric
Review

In vivo monitoring of cellular transplants by magnetic resonance imaging and positron emission tomography

, , &
Pages 145-155 | Published online: 03 Mar 2005

Bibliography

  • COHEN B, PERSIJN GG: Trends in organdonation. Transplant. Proc. (1997) 29:3301–3302.
  • POLLARD S, NASHAN B,JOHNSTON A et al.: A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cylosporin A. Clio. Ther: (2003) 25(6):1654–1669.
  • DUNNETT SB, BJORKLUND A: Introduction. In: Functional Neural Transplantation, SB Dunnett, A Björklund (Eds), Raven Press, New York, NY (1994):1–7.
  • BJORKLUND A, DUNNETT SB, BRUNDIN P et al.: Neural transplantation for the treatment of Parkinson's disease. Lancet Neurol (2003) 2:437–445.
  • REDMOND DE: Cellular replacement therapy for Parkinson's disease — where are we today? Neuroscientist (2002) 8(5):457–488.
  • DALEY GQ: Prospects for stem cell therapeutics: myths and medicines. Carr. Opin. Genet. Dev. (2002) 12:607–613.
  • PICKERING S, BRAUDE P, PATEL M, BURNS CJ, BOLTON V, MINGER S:Preimplantation genetic diagnosis — a novelsource of embryos for human stem cell research. Reprod. Biomed. Online (2003) 7(3):353–364.
  • SMITH A: Embryo-derived stem cells: of mice and men. Anna. Rev Cell Dev. Biol. (2001) 17:435–462.
  • FANDRICH F, LIN X, CHAT GX et al: Preimplantation-stage stem cells induce long-term allogenic graft acceptance without supplementary host conditioning. Nat. Med. (2002) 8(2):171–178.
  • HORI J, NG TF, SHATOS M,KLASSEN H, STREILEINYOUNG MJ: Neural progenitor cells lack immunogenicity and resist destruction as allografts. Stem Cells (2003) 21:405–416.
  • MODO M, REZAIE P, HEUSCHLING P et al.: Transplantation of stem cells in a rat model of stroke: Assessment of short-term graft survival and acute host immunological response. Brain Res. (2002) 958:70–82.
  • ZAVAZAVA N: Embryonic stem cells and potency to induce transplantation tolerance. Expert Opin. Biol. Ther. (2003) 3(1):5–13.
  • MODO M, STROEMER RP, TANG E, PATEL S, HODGES H: Implantation site of stem cell grafts affects behavioural recovery from stroke damage. Stroke (2002) 33(9):2270–2278.
  • PARK KI, OUREDNIK J, OUREDNIK V et al.: Global gene and cell replacement strategies via stem cells. Gene Ther. (2002) 9(10):613–624.
  • WANG X, WILLENBRING H,AKKARI Y et al: Cell fusion is the principle source of bone-marrow-derived hepatocytes. Nature (2003) 422:897–901.
  • VASSILOPOLOUS G, WANG R-P, RUSSEL DW: Transplanted bone-marrow regenerates liver by cell fusion. Nature (2003) 422:901–904.
  • SEABERG RM, VAN DER KOOY D: Stem and progenitor cells: the premature desertion of rigorous definitions. Trends Neurosci. (2003) 26(3):125–131.
  • ROSSI F, CATTANEO E: Neural stem cell therapy for neurological disease: dreams and reality. Nat. Rev Neurosci. (2002) 3(5):401–409.
  • BECKMANN N, HOF RP, RUDIN M: The role of magnetic resonance imaging and spectroscopy in transplantation: from animal models to man. NMR Biomed. (2000) 13:329–348.
  • MODO M, ZELAYA F, LYTHGOE D, BEECH JS, WILLIAMS SCR Contemporary neuroimaging of cerebral ischaemia. In: Pharmacol Cerebral Ischenna 2002, Krieglstein J (Ed.), Medpharm Scientific Publishers, Stuttgart, Germany (2002):37–56.
  • DIJKHUISEN RM, SINGHAL AB, MANDEVILLE JB et al.: Correlation between brain reorganization, ischemic damage, and neurologic status after transient focal cerebral ischemia in rats: a functional magnetic resonance imaging study. J. Neurosci. (2003) 23(2):510–517.
  • VIRLEY D, BEECH JS, SMART SC, WILLIAMS SCR, HODGES H, HUNTER AJ: A temporal MRI assessment of neuropathology after transient middle cerebral artery occlusion in the rat:correlations with behavior. Cereb. Blood Flow Metab. (2000) 20:563–582.
  • FOLKERTH RD, DURSO R: Survival andproliferation of nonneural tissues, with obstruction of cerebral ventricles, in a parkinsonian patient treated with fetal allografts. Neurology (1996) 46(5):1219–1225.
  • HOLDEN C: Cells find destiny through merger. Science (2003) 300:35.
  • NORMAN AB, THOMAS SR,PRATT RG, SAMARATUNGA RC, SANBERG RP: Magnetic resonance imaging of rat brain following acid-induced lesions and fetal striatal tissue transplants. Brain Res. (1989) 483:188–191.
  • NORMAN AB, THOMAS SR, PRATT RG, SAMARATUNGA RC, SANBERG RP: A magnetic resonance imaging contrast agent differentiates between the vascular properties of fetal striatal tissue transplants and gliomas in rat brain in vivo. Brain Res. (1989) 503:156–159.
  • NORMAN AB, THOMAS SR,PRATT RG, SAMARATUNGA RC, SANBERG PR: Ti and T2 weighted magnetic resonance imaging of excitotoxin lesions and neural transplants in rat brain in vivo. Exp. Neurol (1990) 109:164–170.
  • ISENMANN S, BRADNER S,KUHNE G, BONER J, AGUZZI A: Comparative in vivo and pathological analysis of the blood-brain barrier in mouse telencephalic transplants. Neuropathol Appl. Neurobiol (1996) 22:118–128.
  • SCHOCKE MFH, WALDNER R, PUSHBAN Z et al.: ha vivo magnetic resonance imaging of embryonic neural grafts in a rat model of striatonigral degeneration (multiple system atrophy). Neuroimage (2000) 12:209–218.
  • GUZMAN R, MEYER M, LOVBLAD KO et al.: Striatal grafts in a rat model of Huntington's disease: Time course comparison by MRI and histology. Exp. Neurol (1999) 156:180–190.
  • CHEN YC, GALPERN WR, BROWNELL AL et al.: Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data. Magn. Reson. Med. (1997) 38(3):389–398.
  • CHEN YI, BROWNELL A-L, GALPERN W et al.: Detection of dopaminergic cell loss and neural transplantation using pharmacologicalMRI, PET, and behavioral assessment. Neuroreport (1999) 10:2881–2886.
  • ADONAI N, NGUYEN KN, WALSH J et al.: Ex vivo cell labelling with 64C0-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc. Natl. Acad. Sci. USA (2002) 99:3030–3035.
  • PESCHANSKI M, RUDIN M,ISACSON 0, DELEPIERRE M, ROQUES BP: Magnetic resonance imaging of intracerebral neural grafts. Frog. Brain Res. (1988) 78.619–624.
  • PALFI S, NGUYEN JP, BRUGIERES P et al.: MRI-stereotactical approach to neural grafting in basal ganglia disorders. Exp. Neurol (1998) 150.272–281.
  • SIMMONS NE, HELM GA, CAIL WS, BENNET JP, JANE JA: Magnetic resonance imaging of neuronal grafts in the primate. Exp. Neurol (1994) 12:52–57.
  • ELSWORTH JD, AL-TIKRITI MS, SLADEK JR et al.: Novel radioligands for the dopamine transporter demonstrates the presence of intrastriatal nigral grafts in the MPTP-treated monkey: correlation with improved behavioural function. Exp. Neurol (1994) 126:300–304.
  • BACHOUD-LEVI A-C, BOURDET C, BRUGIÈRES P et al: Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease. Exp. Neurol (2000) 161:194–202.
  • BACHOUD-LEVI A-C, RE.MY P, NGUYEN J-P et al.: Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet (2000) 356:1975–1979.
  • PICCINI P, BROOKS DJ,BJORKLUND A et al.: Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat. Neurosci. (1999) 2(12):1137–1140.
  • PICCINI P, LINDVALL 0,BJORKLUND A et al:Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann. Neurol (2000) 48(5):689–695.
  • HAGELL P, SCHRAG A, PICCINI P et al.: Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain (1999) 122(Pt 6):1121–1126.
  • HAGELL P, PICCINI P, BJORKLUND A et al.: Dyskinesias following neural 152transplantation in Parkinson's disease. Nat. NeuroscL (2002) 5(7):627–628.
  • WIRTH ED, REIER PJ, FESSLER RG et al.: Feasability and safety of neural tissue transplantation in patients with syringomyelia. Neurotrauma (2001) 18(9):911–929.
  • KOPYOV OV, JACQUES DB, LIEBERMAN A, DUMA CM, EAGLE KS: Safety of intrastriatal neurotransplantation in Huntington's disease patients. Exp. Neurol. (1998) 49:97–108.
  • SANCHEZ-PERNAUTE R, BROWNELL A-L, ISACSON 0: Functional imaging of the dopamine system: in vivo evaluation of dopamine deficiency and restoration. Neurotoxicology (2002) 23:469–478.
  • ROSSER AE, BARKER RA, HARROWER T et al.: Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475. Neurol. Neuroswg. Psychiatry (2002) 73:678–685.
  • BLOML S, KOPYOV 0, JACQUES S, ROSS BD: Activation of neurotransplants in humans. Exp. Neurol (1999) 158:121–125.
  • SAWLE GV, MYERS R: The role of positron emission tomography in the assessment of human neurotransplantation. Trends Neurosci. (1993) 16:172–176.
  • BRUNDIN P, POGARELL 0, HAGELL P et al: Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain (2000) 123(Pt 7):1380–1390.
  • LINDVALL 0, SAWLE G, WIDNER H et al.: Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann. Neurol. (1994) 35:172–180.
  • FRICKER RA, TORRES EM, HUME SP et al.: The effect of donor stage on the survival and function of embryonic striatal grafts in the adult brain: II. Correlation with positron emission tomography and reaching behaviour. Neuroscience (1997) 79(3):711–721.
  • TORRES EM, FRICKER R, HUME SP et al.: Assessment of striatal graft viability in the rat in vivo using a small diameter PET scanner. Neuroreport (1995) 6:2017–2020.
  • BORWNELL AL, LIVINI E,GALPERN W, ISACSON 0: In vivo PET imaging in rat of dopamine terminals reveals functional neural transplants. Ann. Neurol. (1998) 43:387–390.
  • ROSS BD, HOANG TQ, BLOML Set al.:In vivo magnetic resonance spectroscopy of human fetal neural transplants. NMR Biomed. (1999) 12:221–236.
  • POZZILLI P, POZZILLI C, PANTANO P, NEGRI M, ANDREANI D, CUDWORTH AG: Tracking of indium-111-oxine labelled lymphocytes in autoimmune thyroid disease. Clin. Endrocrinol (1983) 19:111–116.
  • HAWRYLAK N, GHOSH P, BROADUS J et al.: Nuclear magnetic resonance imaging of iron oxide-labelled neural transplants. Exp. Neurol. (1993) 121:181–192.
  • JACOBS RE, FRASER SE: Magnetic resonance microscopy of embryonic cell lineages and movements. Science (1994) 263:681–684.
  • WEISSLEDER R, CHENG HC, BOGDANOVA A, BOGDANOV A: Magnetically labelled cells can be detected by MR imaging. I Magn. Reson. Imaging (1997) 7(1):258–263.
  • NORMAN AB, THOAMS SR, PRATT RG, LU SY, NORGREN RB: Magnetic resonance imaging of neural transplants in rat brain using a superparamagnetic contrast agent. Brain Res. (1992) 594:279–283.
  • BULTE JWM, ZHANG S-C, VAN GELDEREN P et al.: Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc. Natl Acad. Sci. USA (1999) 96(26):15256–15261.
  • LEWIN M, CARLESSO N, TUNG C-H et al.: Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol (2000) 18:410–414.
  • MOORE A, WEISSLEDER R,BOGDANOV A: Uptake of dextran-coated monocrystalline iron oxides in tumour cells and macrophages. J. Magn. Reson. Imaging (1997) 7(6):1140–1145.
  • HOEHN M, KOSTERMANN E, BLUNK J et al.: Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc. Natl Acad. Sci. USA (2002) 99(25):16267–16272.
  • BULTE JW, FRANK JA: Imaging macrophage activity in the brain by using ultrasmall particles of iron oxide. Am. Neuroradiol (2000) 21:1767–1768.
  • DOUSSET V, DELALANDE C, BALLARINO L et al.: Li vivo macrophage activity imaging in the central nervous system detected by magnetic resonance. Magn. Reson. Med. (1999) 41:329–333.
  • DOUSSET V, GOMEZ C, PETRY KG, DELALANDE C, CAILLE JM: Dose and scanning delay using USPIO for central nervous system macrophage imaging. MAGMA (1999) 8(3):185–189.
  • ZHANG RL, ZHANG L, ZHANG ZG et al.: Migration and differentiation of adult rat subventricular zone progenitor cells transplanted into adult rat striatum. Neuroscience (2003) 116(2):373–382.
  • ZHANG ZG, JIANG Q, ZHANG R et al.: Magnetic resonance imaging and neurosphere therapy of stroke in rat. Ann. Neurol. (2003) 53:259–263.
  • BULTE JWM, DOUGLAS T, WITWER B et al.: Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol (2001) 19:1141–1147.
  • KAUFMAN CL, WILLIAMS M, RYLE LM, SMITH TL, TANNER M, HO C: Superparamagnetic iron oxide particles transactivator protein-fluorescein isothiocyanate particle labelling for in vivo magnetic resonance imaging detect of cell migration: Uptake and durability. Transplantation (2003) 76:1043–1046.
  • JENDELOVA P, HERYNEK V,DE CROOS J, GLOGAROVA K, ANDERSSON B, HAJEK M, SYKOVA E: Imaging the fate of implanted bone marrow stromal cells labelled with supraparamagnetic nanoparticles. Magn. Reson. Med. (2003) 50:767–776.
  • HUBER MM, STAUBLI AB, KUSTEDJO K et al.: Fluorescently detectable magnetic resonance imaging agents. Bioconjug. Chem. (1998) 9:242–249.
  • MODO M, CASH D, MELLODEW K et al.: Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage (2002) 17(2):803–811.
  • MODO M, MELLODEW K, CASH D et al.: Mapping transplanted stem cell migration after a stroke: a serial, in vivo 99.magnetic resonance imaging study. Neuroimage (2004) (In Press).
  • BULTE JW, DUNCAN ID, FRANK JA In vivo magnetic resonance tracking of magnetically labelled cells after transplantation. I Cereb. Blood Flow Metab. (2002) 22(8):899–907.
  • BULTE JWM, BEN-HURT, MILLER BR et al.: MR microscopy of magnetically labelled neurospheres transplanted into the Lewis EAE rat brain. Magn. Reson. Med. (2003) 50:201–205.
  • FRANKLIN RJM, BLASCHUK KL, BEARCHELL MZ et al.: Magnetic resonance imaging of transplanted oligodendrocyte precursors in the rat brain. Neuroreport (1999) 10:3961–3965.
  • YEH TC, ZHANG W, ILDSTAD ST, HO C: Intracellular labelling of T-cells with superparamagnetic contrast agents. Magn. Reson. Med. (1993) 30:617–625.
  • YEH TC, ZHANG W, ILDSTAD ST, HO C: In vivo dynamic MRI tracking of rat T-cells labelled with superparamagnetic iron-oxide particles. Magn. Reson. Med. (1995) 33(2):200–208.
  • DODD SJ, WILLIAMS M, SUHAN JP, WILLIAMS DS, KORETSKY AP, HO C: Detection of single mammalian cells by high-resolution magnetic resonance imaging. Biophys. J. (1999) 76:103–109.
  • DOOD CH, HSU HC, CHU WJ et al:Normal T-cell response in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles. Immunol Methods (2001) 256(1-2):89–105.
  • RAUSCH M, SAUTER A, FROHLICH J, NEUBACHER U, RADO EW,RUDIN M: Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage. Magn. Reson. Med. (2001) 46:1018–1022.
  • BECKMANN N, CANNET C, FRINGELI-TANNER M et al.: Macrophage labeling by SPIO as an early marker of allograft chronic rejection in a rat model of kidney transplantation. Magn. Reson. Imaging (2003) 49(3):459–467.
  • FLEIGE G, NOLTE C, SYNOWITZ M, SEEBERGER F, KETTENMANN H, ZIMMER C: Magnetic labeling of activated microglia in experimental gliomas. Neoplasia (2001) 3(6):489–499.
  • HINDS KA, HILL JM, SHAPIRO EM et al.: Highly efficient endosomal labelling of progenitor and stem cells with large magnetic particles allows magnetic imaging of single cells. Blood (2003) 102(3):867–872.
  • SIPE JC, FILIPPI M, MARTINO M et al.: Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents. Magn. Reson. Imaging
  • DE LAQUINTANE BD, DOUSSET V, SOLANILLA A, PETRY KG, RIPOCHE J: Iron particle labeling of haematopoietic progenitor cells: an in vitro study. Biosci. Rep. (2002) 22(5-6):549–554.
  • DALDRUP-LINK HE, RUDELIUS M, OOSTENDORP RAJ et al.: Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology (2003) 228(3):760–767.
  • EVANS A, STEWARD CG, LYBURN ID, GRIER DJ: Imaging in haematopoietic stem cell transplantation. Clin. Radiol. (2003) 58:201–214.
  • GAROT J, UNTERSEEH T, TEIGER E et al.: Magnetic resonance imaging of targeted catheter-based implantation of myogenic precursor cells into infarcted left ventricular myocardium. J. Am. Coll. Cardiol. (2003) 41:1841–1846.
  • KRAITCHMAN, DL, HELDMAN, AW, ATALAR E et al.: In vivo magneticresonance imaging of mesenchymal stemcells in myocardial infarction. Circulation (2003) 107:2290–2293.
  • HILL JM, DICK AJ, RAMAN VK et al.: Serial cardiac magnetic resonance imaging
  • KORNBLUM HI, ARAUJO DM, ANNALA AJ,TATSUKAWA KJ, PHELPS ME, CHERRY SR: In vivo imaging of neuronal activation and plasticity in the rat brain by high resolutionpositron emission tomography (microPET).
  • KOEHNE G, DOUBROVIN M, DOUBROVINA E et al.: Serial in vivo imaging of targeted migration of human HSV-TK-transduced antigen specific
  • ASKENSAY N, FARKAS DL: Optical imaging of PKH-labeled hematopoietic cells in recipient bone marrow in vivo. Stem Cells (2002) 20:501–513.
  • HENDRIKX PJ, MARTENS CM, HAGENBEEK A, KEIJ JF, VISSER JW:Homing of fluorescently labelled murine hematopoietic stem cells. Exp. Hematol (1996) 24:129–140.
  • WANG X, ROSOL M, GE S et al.: Dynamic tracking of human hematopoietic stem cell engraftment using in vivo bioluminescence imaging. Blood (2003) 102:3478–3482.
  • LANZKORN SM, COLLECTOR MI, SHARKIS SJ: Hematopoietic stem cell tracking in vivo: A comparison of short-term and long-term repopulating cells. Blood (1999) 93:1916–1921.
  • OH DJ, LEE GM, FRANCIS K, PALSSON BO: Phototoxicity of the fluorescent membrane dyes PKH2 and PKH26 on the human hematopoietic KG la progenitor cell line. Cytometry (1999) 36:312–318.
  • EVANS A, STEWARD CG, LYBURN ID, GRIER DJ: Imaging in haematopoietic stem cell transplantation. Clin. Radial. (2003) 58:201–214.
  • FRANK, JA, MILLER, BR, ARAB AS et al: Clinically applicable labelling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology (2003) 228(2):480–487.
  • KALISH H, ARBAB AS, MILLER BR et al.: Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: Relationship between relaxivities, electrostatic forces, and chemical composition. Magn. Reson. Med. (2003) 50:275–282.
  • ARBAB AS, BASHAW LA, MILLER BR, JORDAN EK, BULTE JWM,FRANCK JA: Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Transplantation (2003) 76:1123–130.
  • REIMER P, BADER A, VVEISSLEDER R Application of a stable cell culture assay for the functional assessment of novel MR contrast agents. Ear: Radial. (1997) 7(4):527–531.
  • ELIAT PA, LECHAUX D, GERVAIS A et al.: Is magnetic resonance imaging texture analysis a useful tool for cell therapy in vivo monitoring? Anti-Cancer Res. (2001) 21(6A):3857–3860.
  • SCHWARTZ ED, SHUMSKY JS, VVEHRLI S, TESSLER A, MURRAY M, HACKNEY DB: Ex vivo MR determined apparent diffusion coefficients correlate with motor recovery mediated by intraspinal transplants of fibroblasts genetically modified to express BDNF. Exp. Neurol. (2003) 182(1):49–63.
  • BJORKLUND L,SANCHEZ-PERNAUTE R, CHUNG S et al.: Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc. Nati Acad. Sci. USA (2000) 99:2344–2349.
  • MARSDEN PK, STRUL D, KEEVIL SF, WILLIAMS SCR, CASH D: Simultaneous PET and NMR. Br. j Radio]. (2002) 75:S53–S59.
  • AOKI I, TANAKA C, TAKEGAMI T et al: Dynamic activity-induced manganese-dependent contrast magnetic resonance imaging (DAIM MRI). Magn. Reson. Med. (2002) 48(6):927–933.
  • ROBERTS TJ, MODO M, PRICE J, WILLIAMS SCR: MHP-36 stem cell grafts induce a partial functional recovery in the 3-nitroproprionic acid model of Huntington's disease. Exp. Neurol (2003) 181(1):104 (Abstract).
  • FEYDY A, CARLIER R, ROBY-BRAMI A et al.: Longitudinal study of motor recovery after stroke: Recruitment and focusing of brain activation. Stroke (2002) 33:1610–1617.
  • CRAMER SC, NELLES G, BENSON RR et al.: A functional MRI study of subjects recovered from hemiparetic stroke. Stroke (1997) 28:2518–2527.
  • CARAMAZZA A: On drawing inferences about the structure of normal cognitive systems from the analysis of patterns of impaired performance: The case for single-patient studies. Brain Cogn. (1986) 5(1):41–66.
  • LANGSTOW JW, WIDNER H, GOETZ CG et al.: Core assessment program for intracerebral transplantations (CAPIT). Mov. Disord. (1992) 7:2–13.
  • CICCHETTI F, BROWNELL AL, WILLIAMS K, CHEN YI, LIVNI E, ISACSON 0: Neuroinflammation of the nigrostriatal pathway during progressive 6-0HDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur. j Neurosci. (2002) 15:991–998.
  • BATCHELOR PE, PORRITT MJ, MARTINELLO P et al.: Macrophages and microglia produce local trophic gradients that stimulate axonal sprouting toward but not beyond the wound edge. Ma Cell Neurosci. (2002) 21:436–453.
  • BRESJANAC M, SAGEN J, SEIGEL G, PAINO CL, KORDOWERJ, GASH DM: Xenogeneic adrenal medulla graft rejection rather than survival leads to increased rat striatal tyrosine hydroxylaseimmunoreactivity. Neuropathol. Exp. Neurol (1997) 56(5):490–498.
  • MODO M, WILLIAMS SCR: MRI and novel contrast agents for molecular imaging. In: Techniques in Biomedical Imaging in Neuroscience Research, van Bruggen N, Roberts T (Eds), CRC Press, Boca Raton, FL, USA (2003):293–322.
  • LOUIE AY, HUBER MM, AHRENS ET et al.: In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotechnol (2000) 18:321–325.
  • MEADE TJ, TAYLOR AK, BULL SR: New magnetic resonance contrast agents as biochemical reporters. Curt: Opin. Neurobiol (2003) 13:597–602.
  • PODUSLO JF, VVENGENACK TM, CURRAN GL et al.: Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging. Neurobiol Dis. (2002) 11(2):315–329.Affiliation

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.